Ocali­va will con­tin­ue to be avail­able in the EU fol­low­ing Eu­ro­pean court's de­ci­sion

Ad­vanz Phar­ma scored a win for its liv­er dis­ease treat­ment Ocali­va af­ter the Gen­er­al Court of the Eu­ro­pean Union tem­porar­i­ly sus­pend­ed the Eu­ro­pean Com­mis­sion’s de­ci­sion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER